Bridge Biotherapeutics (Korea) Market Value
| 288330 Stock | KRW 3,455 430.00 14.21% |
| Symbol | Bridge |
Bridge Biotherapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Bridge Biotherapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Bridge Biotherapeutics.
| 11/04/2024 |
| 12/04/2024 |
If you would invest 0.00 in Bridge Biotherapeutics on November 4, 2024 and sell it all today you would earn a total of 0.00 from holding Bridge Biotherapeutics or generate 0.0% return on investment in Bridge Biotherapeutics over 30 days. Bridge Biotherapeutics is related to or competes with Settlebank, Hana Financial, Samsung Life, Dongbu Insurance, and Korean Reinsurance. Bridge Biotherapeutics, Inc., a clinical stage biotech company, engages in the development of therapeutics for the treat... More
Bridge Biotherapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Bridge Biotherapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Bridge Biotherapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.64 | |||
| Information Ratio | 0.0279 | |||
| Maximum Drawdown | 25.75 | |||
| Value At Risk | (8.61) | |||
| Potential Upside | 11.42 |
Bridge Biotherapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bridge Biotherapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Bridge Biotherapeutics' standard deviation. In reality, there are many statistical measures that can use Bridge Biotherapeutics historical prices to predict the future Bridge Biotherapeutics' volatility.| Risk Adjusted Performance | 0.0435 | |||
| Jensen Alpha | 0.3985 | |||
| Total Risk Alpha | (0.59) | |||
| Sortino Ratio | 0.0317 | |||
| Treynor Ratio | (0.25) |
Bridge Biotherapeutics Backtested Returns
At this point, Bridge Biotherapeutics is very steady. Bridge Biotherapeutics secures Sharpe Ratio (or Efficiency) of 0.0044, which signifies that the company had a 0.0044% return per unit of risk over the last 3 months. We have found thirty technical indicators for Bridge Biotherapeutics, which you can use to evaluate the volatility of the firm. Please confirm Bridge Biotherapeutics' Risk Adjusted Performance of 0.0435, mean deviation of 5.1, and Downside Deviation of 5.64 to double-check if the risk estimate we provide is consistent with the expected return of 0.0278%. The firm shows a Beta (market volatility) of -1.12, which signifies a somewhat significant risk relative to the market. As the market becomes more bullish, returns on owning Bridge Biotherapeutics are expected to decrease slowly. On the other hand, during market turmoil, Bridge Biotherapeutics is expected to outperform it slightly. Bridge Biotherapeutics right now shows a risk of 6.32%. Please confirm Bridge Biotherapeutics downside deviation, standard deviation, and the relationship between the semi deviation and coefficient of variation , to decide if Bridge Biotherapeutics will be following its price patterns.
Auto-correlation | -0.76 |
Almost perfect reverse predictability
Bridge Biotherapeutics has almost perfect reverse predictability. Overlapping area represents the amount of predictability between Bridge Biotherapeutics time series from 4th of November 2024 to 19th of November 2024 and 19th of November 2024 to 4th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Bridge Biotherapeutics price movement. The serial correlation of -0.76 indicates that around 76.0% of current Bridge Biotherapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.76 | |
| Spearman Rank Test | -0.64 | |
| Residual Average | 0.0 | |
| Price Variance | 44.5 K |
Bridge Biotherapeutics lagged returns against current returns
Autocorrelation, which is Bridge Biotherapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Bridge Biotherapeutics' stock expected returns. We can calculate the autocorrelation of Bridge Biotherapeutics returns to help us make a trade decision. For example, suppose you find that Bridge Biotherapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Bridge Biotherapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Bridge Biotherapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Bridge Biotherapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Bridge Biotherapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Bridge Biotherapeutics Lagged Returns
When evaluating Bridge Biotherapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Bridge Biotherapeutics stock have on its future price. Bridge Biotherapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Bridge Biotherapeutics autocorrelation shows the relationship between Bridge Biotherapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Bridge Biotherapeutics.
Regressed Prices |
| Timeline |
Pair Trading with Bridge Biotherapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bridge Biotherapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bridge Biotherapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Bridge Stock
The ability to find closely correlated positions to Bridge Biotherapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bridge Biotherapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bridge Biotherapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bridge Biotherapeutics to buy it.
The correlation of Bridge Biotherapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bridge Biotherapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bridge Biotherapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bridge Biotherapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Bridge Stock
Bridge Biotherapeutics financial ratios help investors to determine whether Bridge Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bridge with respect to the benefits of owning Bridge Biotherapeutics security.